Question 1

What is Irinotecan?

Accepted Answer

Irinotecan is a chemotherapy medication that belongs to a class of drugs known as topoisomerase inhibitors. It works by interfering with the action of an enzyme called topoisomerase I, which cells need to make copies of their DNA.

By blocking this enzyme, the medication prevents cancer cells from dividing and growing. This mechanism helps to slow or stop the spread of cancer cells throughout the body.

Question 2

What is Irinotecan used for?

Accepted Answer

Irinotecan is used to treat metastatic carcinoma of the colon or rectum .

Question 3

How does Irinotecan work?

Accepted Answer

Mechanism of Action

Irinotecan belongs to a group of medicines called topoisomerase inhibitors. It works by interfering with the genetic material, or DNA, inside cancer cells. For a cancer cell to grow and divide into two new cells, it must first make a copy of its DNA.

The medication targets an enzyme in the body known as topoisomerase I. This enzyme normally helps uncoil and manage DNA during the replication process. When irinotecan blocks this enzyme, it causes the DNA strands to break. These breaks prevent the cell from successfully copying its genetic instructions.

Cell Death

When a cancer cell with damaged DNA tries to divide, the damage becomes permanent. Because the cell cannot repair its DNA or complete the division process, it stops growing and eventually dies. This process helps slow or stop the spread of cancer in the body.

Irinotecan is considered a prodrug, meaning it is converted by the body's own enzymes into a more active form after it is administered. This active form is much more powerful at blocking the topoisomerase enzyme than the original drug itself.

Question 4

What are the brand names for Irinotecan?

Accepted Answer

Irinotecan is sold under the brand name Camptosar .

Question 5

What are the active ingredients in Irinotecan?

Accepted Answer

The active ingredient in Irinotecan is irinotecan .

Question 6

What are the side effects of Irinotecan?

Accepted Answer

Common side effects of Irinotecan may include:

diarrhea

nausea

vomiting

and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Irinotecan?

Accepted Answer

Irinotecan belongs to the topoisomerase inhibitor drug class.

Question 8

What is the dosage of Irinotecan and how do I take it?

Accepted Answer

Administration

Irinotecan is given as an injection into a vein (intravenous infusion) by a doctor or nurse. The infusion usually takes about 90 minutes, though this can vary based on the specific treatment plan and formulation used.

Dosing Schedule

This medication is typically administered in treatment cycles. You may receive an infusion once every week or once every few weeks, followed by a rest period where you do not receive the drug. Your healthcare provider will determine the exact schedule based on your medical condition and how your body responds to the treatment.

Important Considerations

Formulations: There are different types of irinotecan, including a liposomal version. These formulations are not interchangeable and have different dosing requirements.

Pre-medication: Before receiving irinotecan, you may be given other medications to help prevent side effects like nausea and vomiting.

Monitoring: Your doctor will perform regular blood tests to check your blood cell counts and liver function during treatment.

Missed Dose

If you miss an appointment for your irinotecan infusion, contact your healthcare provider immediately to reschedule. It is important to stay on the prescribed schedule for the treatment to be effective.

Question 9

Is Irinotecan safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Irinotecan can cause harm to an unborn baby if used during pregnancy. It is important to inform your healthcare provider if you are pregnant or planning to become pregnant before starting treatment. If pregnancy occurs while using this medication, contact your doctor immediately.

To prevent pregnancy during and after treatment, the following measures are generally recommended:

For women: Use effective contraception during treatment and for 6 months after the last dose.

For men: Use effective contraception if your partner can become pregnant during treatment and for 3 months after the last dose.

Breastfeeding

It is unknown if irinotecan passes into breast milk. Because of the potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment and for at least 7 days after the final dose. Discuss the risks and benefits with your healthcare provider.

Question 10

What forms and strengths does Irinotecan come in?

Accepted Answer

Available Forms

Irinotecan is provided as a concentrated liquid solution that requires dilution before it is administered. It is given by a healthcare professional as an intravenous infusion.

There are two primary types of this medication:

Irinotecan hydrochloride injection: The standard liquid formulation for intravenous use.

Irinotecan liposome injection: A formulation where the active drug is contained within liposomes (small fat-like particles) for intravenous infusion.

Question 11

What is the FDA approval status of Irinotecan?

Accepted Answer

FDA Approval and Indications

Irinotecan is an FDA-approved antineoplastic agent. It is primarily indicated for the treatment of metastatic colorectal cancer, either as a first-line therapy in combination with other medications or as a single agent for patients whose disease has progressed after initial treatment. Additionally, a liposomal formulation of irinotecan is approved for the treatment of metastatic pancreatic adenocarcinoma.

Boxed Warnings

The FDA requires a boxed warning for irinotecan due to the potential for severe, life-threatening complications:

Diarrhea: Irinotecan can cause both early-onset and late-onset diarrhea. Late-onset diarrhea can be severe and lead to dehydration, electrolyte imbalances, or sepsis.

Myelosuppression: The drug may cause significant bone marrow suppression, specifically severe neutropenia, which can lead to serious infections.

Due to these risks, the FDA specifies that irinotecan should be administered only under the supervision of a physician experienced in cancer chemotherapy.

Question 12

What should I know about Irinotecan and withdrawal?

Accepted Answer

Stopping Irinotecan Treatment

Irinotecan is a chemotherapy medication that belongs to a class of drugs known as topoisomerase inhibitors. It works by interfering with the action of an enzyme called topoisomerase I, which cells need to make copies of their DNA.

By blocking this enzyme, the medication prevents cancer cells from dividing and growing. This mechanism helps to slow or stop the spread of cancer cells throughout the body.

While there is no withdrawal process, the decision to stop treatment involves several clinical considerations:

Disease Progression: Stopping chemotherapy may allow the underlying cancer to grow or spread. The decision to discontinue treatment is typically based on the drug's effectiveness, the completion of a treatment cycle, or the patient's overall health.

Lingering Side Effects: Some side effects of irinotecan, such as low blood cell counts or digestive issues, may persist for several days or weeks after the final dose. These are toxic effects of the drug itself rather than symptoms of withdrawal.

Medical Supervision: Patients should not skip doses or stop treatment without consulting their oncologist. If treatment must be stopped due to severe adverse reactions, such as severe diarrhea or infection, a healthcare provider will manage the transition and monitor the patient's recovery.

Irinotecan

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Withdrawal Information

FAQ

Found an Error?